You are here: All Products  > CARsgen Starts US Phase II Trial of CLDN18.2 CAR-T for Gastric Cancer

CARsgen Starts US Phase II Trial of CLDN18.2 CAR-T for Gastric Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products